Logo image of SOAR

VOLATO GROUP INC (SOAR) Stock Fundamental Analysis

NYSEARCA:SOAR - NYSE Arca - US74349W3025 - Common Stock - Currency: USD

2.05  +0.06 (+3.02%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to SOAR. SOAR was compared to 23 industry peers in the Passenger Airlines industry. Both the profitability and financial health of SOAR have multiple concerns. SOAR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SOAR had negative earnings in the past year.
In the past year SOAR has reported a negative cash flow from operations.
SOAR Yearly Net Income VS EBIT VS OCF VS FCFSOAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of SOAR (-194.31%) is worse than 91.30% of its industry peers.
Industry RankSector Rank
ROA -194.31%
ROE N/A
ROIC N/A
ROA(3y)-24.42%
ROA(5y)N/A
ROE(3y)-119.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SOAR Yearly ROA, ROE, ROICSOAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

SOAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SOAR Yearly Profit, Operating, Gross MarginsSOAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

SOAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SOAR has less shares outstanding than it did 1 year ago.
The debt/assets ratio for SOAR is higher compared to a year ago.
SOAR Yearly Shares OutstandingSOAR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
SOAR Yearly Total Debt VS Total AssetsSOAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

SOAR has an Altman-Z score of -4.78. This is a bad value and indicates that SOAR is not financially healthy and even has some risk of bankruptcy.
SOAR's Altman-Z score of -4.78 is on the low side compared to the rest of the industry. SOAR is outperformed by 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.78
ROIC/WACCN/A
WACC11.81%
SOAR Yearly LT Debt VS Equity VS FCFSOAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M

2.3 Liquidity

SOAR has a Current Ratio of 0.66. This is a bad value and indicates that SOAR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.66, SOAR perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
A Quick Ratio of 0.66 indicates that SOAR may have some problems paying its short term obligations.
With a Quick ratio value of 0.66, SOAR perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
SOAR Yearly Current Assets VS Current LiabilitesSOAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SOAR have decreased strongly by -73411.40% in the last year.
EPS 1Y (TTM)-73411.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3025%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOAR Yearly Revenue VS EstimatesSOAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SOAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SOAR Price Earnings VS Forward Price EarningsSOAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOAR Per share dataSOAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VOLATO GROUP INC

NYSEARCA:SOAR (4/17/2025, 8:04:00 PM)

2.05

+0.06 (+3.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)03-26 2025-03-26
Earnings (Next)05-15 2025-05-15
Inst Owners4.23%
Inst Owner ChangeN/A
Ins Owners0.83%
Ins Owner Change-2.15%
Market Cap3.89M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-36.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-21.2
FCFYN/A
OCF(TTM)-20.79
OCFYN/A
SpS74.71
BVpS-10.33
TBVpS-11.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -194.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.42%
ROA(5y)N/A
ROE(3y)-119.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.96
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z -4.78
F-Score4
WACC11.81%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73411.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3025%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1659.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1756.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1720.23%
OCF growth 3YN/A
OCF growth 5YN/A